AsclepiX Therapeutics KOL Lunch New York

May 20, 2019
RSVP for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

AsclepiX Therapeutics
Pri­vate, oph­thal­mol­o­gy fo­cused ear­ly stage com­pany; tech­nol­o­gy out of Johns Hop­kins. Plan­n­ing 4Q19 IND and 1Q20 Ph1/2 ini­ti­a­tion (DME and Wet AMD). AX­T107: nov­el pep­tide in­hibit­ing VEGF and ac­ti­vat­ing... [more in­for­ma­tion]